PETALING JAYA: All eyes will be on boys’ singles shuttler Ayu Fu Sheng (pic) in today’s fourth round of the World Junior Championships, as he not only chases a quarter-final berth but also shoulders ...
Finding new friends when old partners prove less than reliable. Indonesia is just one of many countries and blocs forging new trade deals, as tariffs are hiked, reduced or suspended — often with very ...
Swiss drugmaker Basilea Pharmaceutica (SIX: BSLN) has secured a Biomedical Advanced Research and Development Authority BARDA contract of up to $159 million to advance ceftibuten-ledaborbactam ...
Mary Sage lay frozen in place, in such severe pain she couldn’t will herself off the chiropractor’s table. It was 2015, and Sage, then a 56-year-old program operation analyst at the University of ...
With SCOTUS appeal, AstraZeneca makes last-gasp challenge against Medicare price negotiation program
AstraZeneca is throwing one last Hail Mary following a string of Big Pharma defeats challenging the legality of the Inflation Reduction Act (IRA) Medicare price negotiation program. The British ...
The arrival of GLP-1 receptor agonists and dual agonists has delivered unprecedented efficacy, reframed obesity as a chronic disease, and sparked an industry gold rush. For much of the twentieth ...
BARDA will reimburse Basilea for the costs of bringing the antibiotic to market – including planned Phase III trials. Credit: nobeastsofierce via Shutterstock.com. The Biomedical Advanced Research and ...
Boudin makes a handy breakfast at Ayu Bakehouse, 801 Frenchmen St., wrapped in delicate sheets of pastry for the "boudin boy." The muffuletta sticks manage to contain all the olive salad and salumi ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Chester County biotech company ...
Cresemba ® and Zevtera ®-related revenues rise by 24% to CHF 90.5 million Total revenue grows significantly by 36% to CHF 104.0 million Operating profit surges by 160% to CHF 24.0 million Operating ...
Basilea Pharmaceutica Ltd, Allschwil, a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced that it has entered ...
Swiss drug developer Basilea Pharmaceutica (SIX: BSLN) has entered into an exclusive license agreement with Venatorx Pharmaceuticals, to acquire the global rights to ceftibuten-ledaborbactam ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback